| 1 |
Bremholm L, Funch-Jensen P, Eriksen J, et al.Danish Society for Gastroenterology and Hepatology.Diagnosis, follow-up and treatment[J]. Dan Med J, 2012, 59(8): C4499.
|
| 2 |
Frossard JL, Dumonceau JM.Barrett′s esophagus: epidemiology diagnosis and treatment in 2005 [J]. Rev Med Suisse, 2005, 1(31): 2037-2038, 2040-2041.
|
| 3 |
Wang RH.From reflux esophagitis to Barrett′s esophagus and esophageal adenocarcinoma[J]. World J Gastroenterol, 2015, 21(17): 5210-5219.
|
| 4 |
Cameron AJ, Ott BJ, Payne WS.The incidence of adenocarcinoma in columnar-lined(Barrett′s)esophagus[J]. N Engl J Med, 1985, 313(14): 857-859.
|
| 5 |
Spechler SJ.Clinical practice.Barrett′s Esophagus[J]. N Engl J Med, 2002, 346(11): 836-842.
|
| 6 |
Singh A, Chak A. Advances in the management of Barrett′s esophagus and early esophageal adenocarcinoma[J]. Gastroenterol Rep(Oxf), 2015, 3(4): 303-315.
|
| 7 |
Hao Y, Sood S, Triadafilopoulos G, et al.Gene expression changes associated with Barrett′s esophagus and Barrett′s-associated adenocarcinoma cell lines after acid or bile salt exposure[J]. BMC Gastroenterol, 2007, 7: 24.
|
| 8 |
Haigh CR, Attwood SE, Thompson DG, et al.Gastrin induces proliferation in Barrett′s metaplasia through activation of the CCK2 receptor[J]. Gastroenterology, 2003, 124(3): 615-625.
|
| 9 |
Spechler SJ, Souza RF.Barrett′s esophagus[J]. N Engl J Med, 2014, 371(9): 836-845.
|
| 10 |
Kallam A, Alsop BR, Sharma P. Limitations of endoscopic ablation in Barrett′s esophagus[J]. Expert Rev Gastroenterol Hepatol, 2015, 9(4): 487-496.
|
| 11 |
Antoniou SA, Delivorias P, Antoniou GA, et al.Symptom-focused results after laparoscopic fundoplication for refractory gastroesophageal reflux disease--a prospective study[J]. Langenbecks Arch Surg, 2008, 393(6): 979-984.
|
| 12 |
Nissen R. Gastropexy as the lone procedure in the surgical repair of hiatus hernia[J]. Am J Surg, 1956, 92(3): 389-392.
|
| 13 |
Migaczewski M, Pdziwiatr M, Matok M, et al Laparoscopic Nissen fundoplication in the treatment of Barrett′s esophagus-10 years of experience[J]. Wideochir Inne Tech Maloinwazyjne, 2013, 8(2): 139-145.
|
| 14 |
Draaisma WA, Fegrachi S, Simmermacher RK, et al.Therapy-resistant gastro-oesophageal reflux disease: endoluminal treatment not yet sufficiently compared with the gold standard, the laparoscopic Nissen fundoplication [J]. Ned Tijdschr Geneeskd, 2008, 152(47): 2553-2558.
|
| 15 |
Abbas AE, Deschamps C, Cassivi SD, et al Barrett′s esophagus: the role of laparoscopic fundoplication[J]. Ann Thorac Surg, 2004, 77(2): 393-396.
|
| 16 |
Peters JH, DeMeester TR, Crookes P, et alThe treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with " typical" symptoms[J]. Ann Surg, 1998, 228(1): 40-50.
|
| 17 |
Niebisch S, Fleming FJ, Galey KM, et al Perioperative risk of laparoscopic fundoplication: safer than previously reported-analysis of the American College of Surgeons National Surgical Quality Improvement Program 2005 to 2009[J]. J Am Coll Surg, 2012, 215(1): 61-68；discussion 68-69.
|
| 18 |
Kane TD, Brown MF, Chen MK. Members of the APSA New Technology Committee.Position paper on laparoscopic antireflux operations in infants and children for gastroesophageal reflux disease.American Pediatric Surgery Association[J]. J Pediatr Surg, 2009, 44(5): 1034-1040.
|
| 19 |
Kubiak R, Andrews J, Grant HW.Long-term outcome of laparoscopic nissen fundoplication compared with laparoscopic thal fundoplication in children: a prospective, randomized study[J]. Ann Surg, 2011, 253(1): 44-49.
|
| 20 |
Mehta S, BennettJ, Mahon D, et al.Prospective trial of laparoscopic Nissen fundoplication versus proton pump inhibitor therapy forgastroesophageal reflux disease: Seven-yearfollow-up[J]. J Gastrointest Surg, 2006, 10(9): 1312-1316；Discussion1316-1317.
|
| 21 |
Grubnik VV, Malinovskiǐ AV.Analysis of long-term results of laparoscopic repair of hiatal hernias and Nissen fundoplication[J]. Klin Khir, 2012(10): 34-36.
|
| 22 |
Oberg S, Wenner J, Johansson J, et al.Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma[J]. Ann Surg, 2005, 242(1): 49-54.
|
| 23 |
Chang EY, Morris CD, Seltman AK, et al.The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review[J]. Ann Surg, 2007, 246(1): 11-21.
|
| 24 |
Desai TK, Krishnan K, Samala N, et al.The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett′s oesophagus: a meta-analysis[J]. Gut, 2012, 61(7): 970-976.
|
| 25 |
Hvid-Jensen F, Pedersen L, Drewes AM, et al.Incidence of adenocarcinoma among patients with Barrett′s esophagus[J]. N Engl J Med, 2011, 365(15): 1375-1383.
|
| 26 |
Azarm A, Lukolic I, Shukla M, et alEndoscopic management of Barrett′s esophagus: advances in endoscopic techniques[J]. Dig Dis Sci, 2012, 57(12): 3055-3064.
|
| 27 |
Chennat J, Waxman I. Endoscopic treatment of Barrett′s esophagus: From metaplasia to intramucosal carcinoma[J]. World J Gastroenterol, 2010, 16(30): 3780-3785.
|
| 28 |
Luna RA, Gilbert E, Hunter JG.High-grade dysplasia and intramucosal adenocarcinoma in Barrett′s esophagus: the role of esophagectomy in the era of endoscopic eradication therapy[J]. Curr Opin Gastroenterol, 2012, 28(4): 362-369.
|
| 29 |
O′Connell K, Velanovich V. Effects of Nissen fundoplication on endoscopic endoluminal radiofrequency ablation of Barrett′s esophagus[J]. Surg Endosc, 2011, 25(3): 830-834.
|
| 30 |
Zsolt S, Paszt A, Géczi T, et al.Comparison of surgical patients with gastroesophageal reflux disease and Barrett′s esophagus[J]. Magy Seb, 2014, 67(5): 287-296.
|